RST Introduces 'Demron-C' Line of Covid-19 Anti-Viral, Reusable

RST introduces Demron-C line of Covid-19 anti-viral reusable personal protective equipment (PPE) for Coronavirus first responders & healthcare workers

Development of de-novo coronavirus 3-chymotrypsin-like protease (3CLpro) inhibitors since COVID-19 outbreak: A strategy to tackle challenges of persistent virus infection - ScienceDirect

Demron C Suit – Radiation Shield Technologies

Potential treatments of COVID-19: Drug repurposing and therapeutic interventions - ScienceDirect

What We Read: Pandemic Edition

Development of de-novo coronavirus 3-chymotrypsin-like protease (3CLpro) inhibitors since COVID-19 outbreak: A strategy to tackle challenges of persistent virus infection - ScienceDirect

Repositioning of 8565 Existing Drugs for COVID-19

Canadian manufacturer working to meet demand for COVID tests

Regeneron's antibody COVID-19 treatment is popular in the U.S. — why not in Canada? - National

Development of de-novo coronavirus 3-chymotrypsin-like protease (3CLpro) inhibitors since COVID-19 outbreak: A strategy to tackle challenges of persistent virus infection - ScienceDirect

Reconstructing COVID-19 incidences from positive RT-PCR tests by deconvolution, BMC Infectious Diseases

Sensors, Free Full-Text

COVID drug shows promise in new study — but will patients ever get access?

Development of de-novo coronavirus 3-chymotrypsin-like protease (3CLpro) inhibitors since COVID-19 outbreak: A strategy to tackle challenges of persistent virus infection - ScienceDirect

Canadian researchers lead development and testing of promising treatment for COVID-19 variants